Literature DB >> 23222261

Decreased T-cell repertoire diversity in sepsis: a preliminary study.

Fabienne Venet1, Orchidée Filipe-Santos, Alain Lepape, Christophe Malcus, Françoise Poitevin-Later, Audrey Grives, Nadia Plantier, Nicolas Pasqual, Guillaume Monneret.   

Abstract

OBJECTIVE: Septic syndromes are the leading causes of mortality in intensive care units. In patients, the occurrence of sepsis-induced immune suppression is associated with delayed mortality, although the exact role of lymphocyte dysfunctions is not well established. The objective of this study was to investigate T-cell receptor diversity, an important feature of T-cell response, in patients with septic shock.
DESIGN: Preliminary prospective observational study.
SETTING: Adult intensive care units in a university hospital.
SUBJECTS: Patients with septic shock (n = 41) sampled twice after the onset of shock (early after inclusion [day 1] and at the end of the first week [day 7]).
MEASUREMENTS AND MAIN RESULTS: Using a novel molecular biology technique, the combinatorial diversity of human T-cell receptor β-chain (TRB locus) was measured in peripheral blood. Patients with septic shock presented with a marked decreased T-cell receptor diversity after the onset of shock in comparison with normal values. Importantly, in paired samples, a very steep recovery slope of T-cell receptor diversity, never described in other clinical situations, was observed between day 1 and day 7 (p < 0.0001, Wilcoxon's paired test). Decreased T-cell receptor diversity was associated with mortality (log-rank test, p = 0.0058; hazard ratio = 4.48; 95% confidence interval 1.96-53.32), and the development of nosocomial infections (p < 0.05, Mann-Whitney U test).
CONCLUSION: Our results show for the first time that septic patients present with a marked decreased T-cell receptor diversity that returned rapidly toward normal values over time. This opens novel cognitive research perspectives that deserve to be investigated in experimental models of sepsis. After confirmation in larger cohorts of these preliminary results, T-cell receptor diversity measurements may become a crucial tool to monitor immune functions in ICU patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23222261     DOI: 10.1097/CCM.0b013e3182657948

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  27 in total

1.  Burn injury influences the T cell homeostasis in a butyrate-acid sphingomyelinase dependent manner.

Authors:  Teresa C Rice; Stephanie M Armocida; Joshua W Kuethe; Emily F Midura; Ayushi Jain; David A Hildeman; Daniel P Healy; Erich Gulbins; Charles C Caldwell
Journal:  Cell Immunol       Date:  2016-12-26       Impact factor: 4.868

Review 2.  Molecular and genetic inflammation networks in major human diseases.

Authors:  Yongzhong Zhao; Christian V Forst; Camil E Sayegh; I-Ming Wang; Xia Yang; Bin Zhang
Journal:  Mol Biosyst       Date:  2016-07-19

Review 3.  Advances in the understanding and treatment of sepsis-induced immunosuppression.

Authors:  Fabienne Venet; Guillaume Monneret
Journal:  Nat Rev Nephrol       Date:  2017-12-11       Impact factor: 28.314

Review 4.  Impact of sepsis on CD4 T cell immunity.

Authors:  Javier Cabrera-Perez; Stephanie A Condotta; Vladimir P Badovinac; Thomas S Griffith
Journal:  J Leukoc Biol       Date:  2014-05-02       Impact factor: 4.962

Review 5.  The new normal: immunomodulatory agents against sepsis immune suppression.

Authors:  Noelle A Hutchins; Jacqueline Unsinger; Richard S Hotchkiss; Alfred Ayala
Journal:  Trends Mol Med       Date:  2014-01-30       Impact factor: 11.951

6.  Bone marrow is the preferred site of memory CD4+ T cell proliferation during recovery from sepsis.

Authors:  Tomasz Skirecki; Patrycja Swacha; Grażyna Hoser; Jakub Golab; Dominika Nowis; Ewa Kozłowska
Journal:  JCI Insight       Date:  2020-05-21

Review 7.  Defects in innate and adaptive immunity in patients with sepsis and health care associated infection.

Authors:  Thomas Ryan; John D Coakley; Ignacio Martin-Loeches
Journal:  Ann Transl Med       Date:  2017-11

8.  Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge.

Authors:  Javier Cabrera-Perez; Stephanie A Condotta; Britnie R James; Sakeen W Kashem; Erik L Brincks; Deepa Rai; Tamara A Kucaba; Vladimir P Badovinac; Thomas S Griffith
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

Review 9.  Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.

Authors:  Naeem K Patil; Julia K Bohannon; Edward R Sherwood
Journal:  Pharmacol Res       Date:  2016-07-25       Impact factor: 7.658

Review 10.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.